The Scottish Medicines Consortium (SMC) has approved Libmeldy® (atidarsagene autotemcel) gene therapy for use in Scotland.
Alex TLC was proud to contribute to the assessment and approval process alongside other patient organisations, helping to ensure the voices of affected families were heard.
To find out more, visit the SMC website.
